Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

TSLX February 13, 2026

Sixth Street Specialty Lending Q4 2025 Earnings Call - Portfolio Credit Resilience amid an AI-Driven Equity Rerate

Sixth Street reported a quarter and year that read like a defense plan executed well. Q4 adjusted net investment income covered the base dividend, NAV held near prior year levels, and management leane...

  • Q4 adjusted net investment income was $0.52 per share, covering the base quarterly dividend of $0.46 and providing 113% base dividend coverage.
  • Full year 2025 adjusted net investment income was $2.18 per share, an operating ROE of 12.7%, and adjusted net income per share was $1.76, a net income ROE of 10.3%.
  • Reported NAV per share at year-end was $16.98, down slightly from prior quarters after accounting for supplemental dividends and reversals.
  • +12 more takeaways
KNSL February 13, 2026

Kinsale Capital Group Q4 2025 Earnings Call - Expense and AI-driven productivity sustain high ROE as large commercial property softens

Kinsale reported strong profitability in Q4 2025, with diluted operating EPS up 26% year over year, a 71.7% combined ratio for the quarter, and a full-year operating ROE of 26%. Growth was muted overa...

  • Diluted operating EPS rose 26% year over year, to $5.81 for Q4 2025, versus $4.62 in Q4 2024.
  • Quarterly combined ratio was a strong 71.7%, aided by about four points of net favorable prior-year reserve development.
  • Full-year operating return on equity was 26%.
  • +13 more takeaways
TRP February 13, 2026

TC Energy Fourth Quarter 2025 Earnings Call - CAD6B Run-Rate Reconfirmed, Optionality to Rise

TC Energy closed 2025 on a delivery streak. The company reported strong operational results, reiterated its CAD 6 billion annual net capital target through 2030, and flagged a deep pipeline that gives...

  • Company delivered strong operational results and reiterated CAD 6 billion annual net capital target through 2030, with visibility to exceed that level in the latter part of the decade.
  • François: company replaced nearly all EBITDA lost from the liquids spin in less than 18 months by focusing on natural gas and power projects.
  • Q4 comparable EBITDA grew 13% year-over-year for the quarter, while management also cited a 9% year-over-year increase in comparable EBITDA for the broader reporting period in prepared remarks.
  • +16 more takeaways
MGA February 13, 2026

Magna International Fourth Quarter Full Year 2025 Earnings Call - Margin Expansion Backed by Cash, But Some Gains Are Nonrecurring

Magna closed 2025 with stronger-than-expected execution: Q4 sales rose 2% to $10.8 billion, adjusted EBIT margin widened 100 basis points to 7.5%, adjusted EPS jumped 29% to $2.18, and the company gen...

  • Q4 2025 sales were $10.8 billion, up 2% year-over-year; full-year sales were $42 billion, down slightly vs 2024.
  • Q4 adjusted EBIT margin expanded 100 basis points to 7.5%; adjusted EBIT rose 18% to $814 million.
  • Adjusted EPS for Q4 was $2.18, up 29% year-over-year; full-year adjusted EPS was $5.73, up 6%.
  • +12 more takeaways
AAP February 13, 2026

Advance Auto Parts Q4 2025 Earnings Call - Margin Turnaround Underway, But Sales and Cash Recovery Remain Fragile

Advance Auto Parts says the painful reset of its footprint and merchandising is paying off, with 2025 closing as a clear operational inflection point. The company returned to positive comparable sales...

  • Advance returned to positive comparable sales in 2025 after three years of declines, with full-year comps just under 1% and Q4 comps +1.1%.
  • Adjusted operating income margin improved to 2.5% for full-year 2025, up ~210 basis points year over year, driven by merchandising and footprint actions.
  • Management targets 2026 adjusted operating income margin of 3.8% to 4.5%, implying 130 to 200 basis points of expansion versus 2025.
  • +17 more takeaways
IR February 13, 2026

Ingersoll Rand Q4 2025 Earnings Call - Recurring revenue and M&A engine to offset tariff headwinds while guidance assumes modest organic growth

Ingersoll Rand closed 2025 with positive momentum: low single-digit organic order growth, revenue growth driven by both price and volume, and a recurring revenue base that crossed $450 million with a ...

  • Company finished 2025 with low single-digit organic order growth for Q4 and the full year; total revenue up 6% for the year and up 10% in Q4.
  • Recurring revenue exceeded $450 million in 2025, with roughly $1.1 billion of future recurring revenue backlog from existing contracts.
  • Management invested $525 million across 16 acquisitions in 2025, generating about $275 million in annualized inorganic revenue and averaging a 9x pre-synergy multiple.
  • +16 more takeaways
CAE February 13, 2026

CAE Q3 FY2026 Earnings Call - Transformation Launched: 10% of Commercial Sims Targeted for Rationalization to Boost Returns

CAE reported a solid Q3 with revenue of CAD 1.25 billion and improving cash generation, but management signaled a deliberate pivot from growth-at-all-costs to a disciplined, return-first playbook. The...

  • Q3 consolidated revenue was CAD 1.25 billion, up 2% year over year.
  • Adjusted Segment Operating Income was CAD 195.8 million, up 3% year over year; adjusted EPS was CAD 0.34 versus CAD 0.29 a year ago.
  • CAE recorded CAD 7.3 million of transformation-related expenses in Q3, included in adjusted results and shaving roughly CAD 0.02 from adjusted EPS.
  • +17 more takeaways
MRNA February 13, 2026

Moderna Q4 2025 Earnings Call - mNEXSPIKE momentum, FDA refusal to file on flu clouds U.S. path

Moderna closed 2025 with $1.9 billion in revenue, deep cost cuts and a stronger cash position than expected, but a regulatory blow in the U.S. has introduced fresh uncertainty. mNEXSPIKE launched stro...

  • Total 2025 revenue was $1.9 billion, with Q4 revenue of $700 million split roughly $300 million U.S. and $400 million international.
  • Net loss for 2025 was $2.8 billion, loss per share $7.26, improved from a $3.6 billion loss in 2024.
  • Cash and investments ended 2025 at $8.1 billion, including a $600 million initial draw on a $1.5 billion credit facility; excluding that draw cash would have been about $7.6 billion.
  • +15 more takeaways
XAIR February 13, 2026

Beyond Air Q3 FY2026 Earnings Call - 105% Revenue Gain as Gen2 FDA Review and Commercial Scale Become the Story

Beyond Air delivered a strong commercial quarter, with revenue up 105% year-over-year to $2.2 million and sequential growth of 21%. Management emphasized commercial traction for the first‑generation L...

  • Revenue rose 105% year-over-year to $2.2 million for Q3 FY2026, and was up 21% sequentially versus the prior quarter.
  • Gross profit turned positive at $300,000, compared with a gross loss of $200,000 a year ago and a prior-quarter gross loss of $300,000.
  • Installed base and retention: Beyond Air reported LungFit PH in more than 45 hospitals, customer retention above 90%, and over half of customers under multi‑year agreements.
  • +12 more takeaways
ATCH February 13, 2026

AtlasClear Holdings Fiscal Second Quarter 2026 Earnings Call - Inflection: Revenue +84%, Net Income and Positive Equity

AtlasClear says the December quarter marked an inflection point. Revenue jumped to $5.1 million, up 84% year over year, while the company reported net income of $6.8 million and flipped stockholders' ...

  • Revenue for the quarter was $5.1 million, an 84% increase year over year.
  • Reported net income was $6.8 million, which includes non‑cash fair value adjustments.
  • Stockholders' equity turned positive to $21.7 million, up from a deficit of $6.8 million at fiscal year‑end; management says equity rose nearly $60 million since year‑end 2024.
  • +12 more takeaways